An Exceedingly Rare Case of Liraglutide-Induced Liver Injury

Swetha Parvataneni; Rajarajeshwari Ramachandran; Eric Then; Tyler Grantham; Vinaya Gaduputi

doi:10.1155/2021/6306149

An Exceedingly Rare Case of Liraglutide-Induced Liver Injury

Case Rep Gastrointest Med. 2021 Aug 23:2021:6306149. doi: 10.1155/2021/6306149. eCollection 2021.

Authors

Swetha Parvataneni¹, Rajarajeshwari Ramachandran², Eric Then², Tyler Grantham³, Vinaya Gaduputi⁴

Affiliations

¹ Department of Internal Medicine, Geisinger Lewistown Hospital, Lewiston, Pennsylvania, USA.
² Department of Gastroenterology, Brooklyn Hospital Center, Brooklyn, New York, USA.
³ St. George's University, St. George, Grenada.
⁴ Department of Gastroenterology, Blanchard Valley Health System, Findlay, Ohio, USA.

Abstract

Liraglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist used for the treatment of type 2 diabetes mellitus. We are reporting the second case of liraglutide-induced liver injury, with complete resolution of liver injury after discontinuation of the drug.

Publication types

Case Reports